Log in to save to my catalogue

Insulin/IGF1 signalling mediates the effects of β2‐adrenergic agonist on muscle proteostasis and gro...

Insulin/IGF1 signalling mediates the effects of β2‐adrenergic agonist on muscle proteostasis and gro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f341a8776db04f97b5771d9cee49e3e4

Insulin/IGF1 signalling mediates the effects of β2‐adrenergic agonist on muscle proteostasis and growth

About this item

Full title

Insulin/IGF1 signalling mediates the effects of β2‐adrenergic agonist on muscle proteostasis and growth

Publisher

Hoboken: John Wiley and Sons Inc

Journal title

Journal of cachexia, sarcopenia and muscle, 2019-04, Vol.10 (2), p.455-475

Language

English

Formats

Publication information

Publisher

Hoboken: John Wiley and Sons Inc

More information

Scope and Contents

Contents

Background
Stimulation of β2‐adrenoceptors can promote muscle hypertrophy and fibre type shift, and it can counteract atrophy and weakness. The underlying mechanisms remain elusive.
Methods
Fed wild type (WT), 2‐day fasted WT, muscle‐specific insulin (INS) receptor (IR) knockout (M‐IR−/−), and MKR mice were studied with regard to acute eff...

Alternative Titles

Full title

Insulin/IGF1 signalling mediates the effects of β2‐adrenergic agonist on muscle proteostasis and growth

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f341a8776db04f97b5771d9cee49e3e4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f341a8776db04f97b5771d9cee49e3e4

Other Identifiers

ISSN

2190-5991,2190-6009

E-ISSN

2190-6009

DOI

10.1002/jcsm.12395

How to access this item